These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 31305690)
1. Erratum: Safety and efficiency of SGLT2 inhibitor combining with insulin in subjects with diabetes: Systematic review and meta-analysis of randomized controlled trials: Erratum. Medicine (Baltimore); 2017 Jun; 96(26):e7458. PubMed ID: 31305690 [TBL] [Abstract][Full Text] [Related]
2. Comparison between SGLT2 inhibitors and DPP4 inhibitors added to insulin therapy in type 2 diabetes: a systematic review with indirect comparison meta-analysis. Min SH; Yoon JH; Hahn S; Cho YM Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27155214 [TBL] [Abstract][Full Text] [Related]
4. Erratum: A meta-analysis and systematic review of randomized controlled trials with degarelix versus gonadotropin-releasing hormone agonists for advanced prostate cancer: Erratum. Medicine (Baltimore); 2016 Dec; 95(49):e5671. PubMed ID: 31265671 [TBL] [Abstract][Full Text] [Related]
5. Erratum: Pulmonary Toxicities of Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials: Erratum. Medicine (Baltimore); 2016 Jul; 95(30):e156a. PubMed ID: 31265613 [TBL] [Abstract][Full Text] [Related]
6. SGLT2 inhibitor plus DPP-4 inhibitor as combination therapy for type 2 diabetes: A systematic review and meta-analysis. Li D; Shi W; Wang T; Tang H Diabetes Obes Metab; 2018 Aug; 20(8):1972-1976. PubMed ID: 29573110 [TBL] [Abstract][Full Text] [Related]
7. Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis. Wu JH; Foote C; Blomster J; Toyama T; Perkovic V; Sundström J; Neal B Lancet Diabetes Endocrinol; 2016 May; 4(5):411-9. PubMed ID: 27009625 [TBL] [Abstract][Full Text] [Related]
8. Erratum: Braun Enteroenterostomy Following Pancreaticoduodenectomy: A Systematic Review and Meta-Analysis: Erratum. Medicine (Baltimore); 2016 Jun; 95(24):e2208. PubMed ID: 31265591 [TBL] [Abstract][Full Text] [Related]
9. Sodium-Glucose Co-Transporter 2 Inhibitors Compared with Sulfonylureas in Patients with Type 2 Diabetes Inadequately Controlled on Metformin: A Meta-Analysis of Randomized Controlled Trials. Chen Z; Li G Clin Drug Investig; 2019 Jun; 39(6):521-531. PubMed ID: 31041606 [TBL] [Abstract][Full Text] [Related]
10. Effects of Sodium-glucose Cotransporter 2 Inhibitor Monotherapy on Weight Changes in Patients With Type 2 Diabetes Mellitus: a Bayesian Network Meta-analysis. Wang H; Yang J; Chen X; Qiu F; Li J Clin Ther; 2019 Feb; 41(2):322-334.e11. PubMed ID: 30711143 [TBL] [Abstract][Full Text] [Related]
11. Erratum: The role of antiangiogenic agents in the treatment of gastric cancer: A systematic review and meta-analysis: Erratum. Medicine (Baltimore); 2017 Jun; 96(23):e7230. PubMed ID: 31305673 [TBL] [Abstract][Full Text] [Related]
12. Erratum: Treatments for Shoulder Impingement Syndrome: A PRISMA Systematic Review and Network Meta-Analysis: Erratum. Medicine (Baltimore); 2016 Jun; 95(23):e96d5. PubMed ID: 31265590 [TBL] [Abstract][Full Text] [Related]
13. Systematic Review and Meta-Analysis of Randomized Controlled Trials on the Effect of SGLT2 Inhibitor on Blood Leptin and Adiponectin Level in Patients with Type 2 Diabetes. Wu P; Wen W; Li J; Xu J; Zhao M; Chen H; Sun J Horm Metab Res; 2019 Aug; 51(8):487-494. PubMed ID: 31408894 [TBL] [Abstract][Full Text] [Related]
14. Erratum: Chinese Herbal Medicine for Symptom Management in Cancer Palliative Care: Systematic Review And Meta-analysis: Erratum. Medicine (Baltimore); 2016 May; 95(20):e6650. PubMed ID: 31265583 [TBL] [Abstract][Full Text] [Related]
15. Erratum: Acupuncture and Related Therapies for Symptom Management in Palliative Cancer Care: Systematic Review and Meta-Analysis: Erratum. Medicine (Baltimore); 2016 May; 95(20):e90e6. PubMed ID: 31265589 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of sodium-glucose cotransporter 2 (SGLT2) inhibitors in type 1 diabetes: A systematic review and meta-analysis. El Masri D; Ghosh S; Jaber LA Diabetes Res Clin Pract; 2018 Mar; 137():83-92. PubMed ID: 29317332 [TBL] [Abstract][Full Text] [Related]
17. SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials. Tang H; Dai Q; Shi W; Zhai S; Song Y; Han J Diabetologia; 2017 Oct; 60(10):1862-1872. PubMed ID: 28725912 [TBL] [Abstract][Full Text] [Related]
18. Erratum: Incidence of Augmentation in Primary Restless Legs Syndrome Patients May Not Be That High: Evidence From A Systematic Review and Meta-Analysis: Erratum. Medicine (Baltimore); 2016 Feb; 95(6):e2504. PubMed ID: 31265677 [TBL] [Abstract][Full Text] [Related]
19. Erratum: Is obesity a predisposing factor for free flap failure and complications? Comparison between breast and nonbreast reconstruction: Systematic review and meta-analysis: Erratum. Medicine (Baltimore); 2017 Feb; 96(7):e6213. PubMed ID: 31305747 [TBL] [Abstract][Full Text] [Related]
20. Effect of SGLT2 inhibitor on renal function in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Feng C; Wu M; Chen Z; Yu X; Nie Z; Zhao Y; Bao B Int Urol Nephrol; 2019 Apr; 51(4):655-669. PubMed ID: 30830656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]